Cancer drug list and your Shield plan: how the 2022 changes work
MediShield Life and Integrated Shield Plans pay for outpatient cancer drugs against a defined Cancer Drug List rather than the full bill. Here is how the limits work.
Cancer treatment is one of the largest and least predictable costs a Shield plan has to absorb, because a patient can move through several drug regimens over a single illness, each priced very differently. MediShield Life and Integrated Shield Plans (IPs) manage this by paying against a Cancer Drug List, a schedule of specific outpatient cancer treatments with defined claim limits, rather than reimbursing whatever a clinic happens to charge. Understanding how that list works matters as much as understanding your ward class, because it decides how much of an outpatient cancer bill actually gets paid.
Why a list, rather than "as charged"
Cancer drugs vary enormously in price, and the same clinical outcome can sometimes be achieved with treatments that differ several times over in cost. A scheme that simply reimbursed whatever was billed would have no way to steer patients or clinics toward treatments that are both clinically appropriate and reasonably priced, and premiums across the whole risk pool would have to rise to match. The Cancer Drug List sets out which outpatient cancer treatments are claimable under MediShield Life, and the corresponding claim limits, so that the scheme's cost stays predictable while still covering treatments that are demonstrated to work.
An IP's private layer generally follows the same claimable-list approach for the treatments MediShield Life already covers, and where a rider is involved, some riders extend cover to selected cancer drug treatments that sit outside the standard list, at an additional premium. If a newer drug or a treatment you are considering is not on the list, ask your insurer directly rather than assuming it is either covered or excluded.
What MediSave allows you to claim
Separate from the Cancer Drug List's insurance claim limits, MediSave itself can be used for approved outpatient cancer treatments at specialist outpatient clinics, subject to monthly limits that depend on the specific drug treatment, commonly in the few-hundred to low-thousand dollar range per month per patient. Cancer drug services and related scans carry their own annual limit. Patients being treated for more than one primary cancer at the same time can, on an application basis assessed by the Ministry of Health, claim up to the combined limit of the highest qualifying treatments for each cancer. Radiotherapy sits on a separate schedule, with limits that vary by the type of radiotherapy given, from external beam treatments at the lower end to procedures like radiosurgery at the higher end.
These MediSave withdrawal limits and the MediShield Life/IP claim limits are not the same thing and can move independently when either scheme is reviewed, so treat any specific dollar figure as a snapshot rather than a permanent number, and check the current schedule on the MOH website before relying on it for a treatment decision.
What this means in practice for a patient
- Ask early which list a proposed treatment sits on. Your oncologist's team or your insurer can usually confirm whether a specific drug is on the Cancer Drug List and at what claim limit, before treatment starts rather than after the bill arrives.
- Understand the gap between the claim limit and the actual cost. If a treatment's real cost regularly exceeds the claim limit, that gap is paid out of pocket, MediSave subject to its own limit, or by a rider if you have one that extends to the treatment.
- Multiple primary cancers need a specific application. Do not assume the higher combined limit applies automatically; it is assessed case by case.
- Re-check before switching treatments. A change in drug regimen partway through treatment can move you to a different limit on the list.
Where this fits with the rest of your cover
A Cancer Drug List limit is about the outpatient drug bill specifically. It sits alongside, not instead of, whatever inpatient cover your MediShield Life or IP provides for a hospital admission, and alongside any standalone critical illness plan you hold, which pays a lump sum on diagnosis regardless of what the drugs cost. If you are trying to work out whether your current combination of Shield plan, rider and critical illness cover would actually hold up against a real cancer diagnosis, our coverage gap check is a reasonable starting point, and you can compare current health plans at /compare/singapore/health.
Talk to an advisor
The Cancer Drug List and its claim limits are reviewed periodically, and the gap between what a plan pays and what treatment costs is exactly the kind of detail that is easy to misjudge from the outside. A licensed advisor can check a specific treatment against your current plan and rider, if any, before you need to rely on it. Use the portal's advisor matching to find one, or ask our assistant to explain how a plan's cancer drug cover works.
Sources
This content is educational information from a licensed advisor, not financial advice. Product details vary by insurer — verify specifics with an advisor.
